Progesterone crosstalks with insulin-like growth factor signaling in breast cancer cells via induction of insulin receptor substrate-2

Oncogene

Volumn 22, Issue 44, 2003, Pages 6937-6941

  Cui, Xiaojiang ^a   Lazard, Za Waunyka ^a   Zhang, Ping ^a   Hopp, Torsten A ^a   Lee, Adrian V ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Breast cancer; IGFs; IRS 2; Phosphorylation; Progesterone; R5020

Indexed keywords

ANTIGESTAGEN; ESTROGEN RECEPTOR; GESTAGEN; GROWTH FACTOR RECEPTOR BOUND PROTEIN 2; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; MESSENGER RNA; MIFEPRISTONE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROGESTERONE; PROGESTERONE RECEPTOR; PROGESTERONE RECEPTOR A; PROGESTERONE RECEPTOR B; PROMEGESTONE; PROTEIN KINASE B; PROTEIN P85; PROTEIN SUBUNIT; REGULATOR PROTEIN; SOMATOMEDIN; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER GROWTH; CELL LEVEL; CELL STIMULATION; CELL STRAIN MCF 7; CONTROLLED STUDY; ENZYME ACTIVATION; GROWTH REGULATION; HORMONAL REGULATION; HORMONE ACTION; HUMAN; HUMAN CELL; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION;

BREAST NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HORMONE ANTAGONISTS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MIFEPRISTONE; PHOSPHOPROTEINS; PROGESTERONE; PROGESTINS; PROMEGESTONE; PROTEIN ISOFORMS; RECEPTOR, INSULIN; RECEPTORS, PROGESTERONE; RNA, MESSENGER; SIGNAL TRANSDUCTION; SOMATOMEDINS; UP-REGULATION;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0242574322     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206803     Document Type: Article

References (27)

1. Baserga R. (1995). Cancer Res., 55, 249-252.
2. Bruning JC, Winnay J, Cheatham B and Kahn CR. (1997). Mol. Cell Biol., 17, 1513-1521.
3. Chang Q, Li Y, White MF, Fletcher JA and Xiao S. (2002). Cancer Res., 62 (21), 6035-6038.
4. Dupont J and Le Roith D. (2001). Mol. Pathol., 54, 149-154.
5. Graham JD and Clarke CL. (1997). Endocr. Rev., 18, 502-519.
6. Groshong SD, Owen GI, Grimison B, Schauer IE, Todd MC, Langan TA, Sclafani RA, Lange CA and Horwitz KB. (1997). Mol. Endocrinol., 11, 1593-1607.
7. Jackson JG, White MF and Yee D. (1998). J. Biol. Chem., 273, 9994-10003.
8. Kastner P, Krust A, Turcotte B, Stropp U, Tora L, Gronemeyer H and Chambon P. (1990). EMBO J., 9, 1603-1614.
9. Lange CA, Richer JK, Shen T and Horwitz KB. (1998). J. Biol. Chem., 273, 31308-31316.
10. Lapidus RG, Nass SG and Davidson NE. (1998). J. Mamm. Gland Biol. Neoplasia, 3, 85-94.
11. Lee AV, Jackson JG, Gooch J L, Hilsenbeck SG, Coronado-Heinsohn E, Osborne CK and Yee D. (1999). Mol. Endocrinol., 13, 787-796.
12. Lee AV and Yee D. (1995). Biomed. Pharmacother., 49, 415-421.
13. LeRoith D. (1996). Baillieres Clin. Endocrinol. Metab., 10, 49-73.
14. Lin VC, Ng EH, Aw SE, Tan MG, Chan VS and Ho GH. (1999). Clin. Cancer Res., 5, 395-403.
15. Musgrove EA, Lee CS and Sutherland RL. (1991). Mol. Cell. Biol., 11, 5032-5043.
16. Oesterreich S, Zhang P, Guler RL, Sun X, Curran EM, Welshons WV, Osborne CK and Lee AV. (2001). Cancer Res., 61, 5771-5777.
17. Richer JK, Jacobsen BM, Manning NG, Abel MG, Wolf DM and Horwitz KB. (2002). J. biol. Chem., 277, 5209-5218.
18. Rocha RL, Hilsenbeck SG, Jackson JG, VanDenBerg CL, Weng C, Lee AV and Yee D. (1997). Clin. Cancer Res., 3, 103-109.
19. Ross RK, Paganini-Hill A, Wan PC and Pike MC. (2000). J. Natl. Cancer Inst., 92, 328-332.
20. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM and Ockene J. (2002). JAMA, 288, 321-333.
21. Schairer C, Lubin J, Troisi R, Sturgeon S, Brinton L and Hoover R. (2000). JAMA, 283, 485-491.
22. Shaw LM. (2001). Mol. Cell. Biol., 21, 5082-5093.
23. Surmacz E and Burgaud JL. (1995). Clin. Cancer Res., 1, 1429-1436.
24. Vassen L, Wegrzyn W and Klein-Hitpass L. (1999). Mol. Endocrinol., 13, 485-494.
25. Vegeto E, Shahbaz MM, Wen DX, Goldman ME, O'Malley BW and McDonnell DP. (1993). Mol. Endocrinol., 7, 1244-1255.
26. Wen DX, Xu YF, Mais DE, Goldman ME and McDonnell DP. (1994). Mol. Cell. Biol., 14, 8356-8364.
27. Yenush L and White MF. (1997). BioEssays, 19, 491-500.